Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Snyder et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69d9d8fc84371aa676a3c136 — DOI: https://doi.org/10.1056/nejmoa1406498

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. A Comprehensive Vertebrate Phylogeny Using Vector Representations of Protein Sequences from Whole Genomes· 2002 · 114 citations
2. Molecular Requirements for T Cell Recognition of N-Myristoylated Peptides Derived from the Simian Immunodeficiency Virus Nef Protein· 2012 · 14 citations
3. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope· 1987 · 293 citations
4. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies· 2009 · 949 citations
5. Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma· 2012 · 40 citations